<!DOCTYPE html
  PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:n1="urn:hl7-org:v3">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
   
      <title>Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control</title><style type="text/css">
body {
	color: rgb(26, 26, 26);
	background-color: rgb(255,255,255);
	font-family: Verdana, Tahoma, sans-serif;
	font-size: 11px;
}

a {
	color: rgb(0, 0, 255);
	background-color: rgb(255,255,255);
}

h1 {
	font-size: 12pt;
	font-weight: bold;
}

h2 {
	font-size: 11pt;
	font-weight: bold;
}

h3 {
	font-size: 10pt;
	font-weight: bold;
}

h4 {
	font-size: 8pt;
	font-weight: bold;
}

div {
	width: 80%;
}

table {
	line-height: 10pt;
	width: 80%;
}

tr {
	background-color: rgb(224,224,224);
}

td {
	padding: 0.1cm 0.2cm;
	vertical-align: top;
}

.h1center {
	font-size: 12pt;
	font-weight: bold;
	text-align: center;
	width: 80%;
}

.header_table{
	border: 1pt inset rgb(0,0,0);
}

.narr_table {
	width: 100%;
}

.narr_tr {
	background-color: rgb(225,225,225);
}
pre {
 overflow: auto; /* Use horizontal scroller if needed; for Firefox 2, not needed in Firefox 3 */
 white-space: pre-wrap; /* css-3 */
 white-space: -moz-pre-wrap !important; /* Mozilla, since 1999 */
 white-space: -pre-wrap; /* Opera 4-6 */
 white-space: -o-pre-wrap; /* Opera 7 */
 word-wrap: break-word; /* Internet Explorer 5.5+ */
 font-family: Verdana, Tahoma, sans-serif;
 font-size: 11px;
 text-align:left;
 margin: 0px 0px 0px 0px;
 padding:0px 0px 0px 0px;
}
.narr_th {
	background-color: rgb(201,201,201);
}

.td_label{
	font-weight: bold;
	color: white;
}
	</style></head>
   <body>
      <table class="header_table">
         <tbody>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Title</span></td>
               <td width="80%" colspan="3">Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Identifier<br>(Measure Authoring Tool)</span></td>
               <td width="30%">182</td>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Version number</span></td>
               <td width="30%">1</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">NQF Number</span></td>
               <td width="30%">0075</td>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">GUID</span></td>
               <td> 500e4792-7f94-4e34-8546-ee71c56fe463</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measurement Period</span></td>
               <td width="80%" colspan="3">January 1, 20xx  through December 31, 20xx </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Steward</span></td>
               <td width="80%" colspan="3">National Committee for Quality Assurance</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Developer</span></td>
               <td width="80%" colspan="3">National Committee for Quality Assurance</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Endorsed By</span></td>
               <td width="80%" colspan="3">National Quality Forum</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Description</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) in the 12 months prior to the measurement period, or who had an active diagnosis of ischemic vascular disease (IVD) during the measurement period, and who had a complete lipid profile performed during the measurement period and whose LDL-C was adequately controlled (&lt; 100 mg/dL).</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Copyright</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Physician Performance Measure (Measures) and related data specifications were developed by the National Committee for Quality Assurance (NCQA). 

The Measures are copyrighted but can be reproduced and distributed, without modification, for noncommercial purposes (e.g., use by healthcare providers in connection with their practices). Commercial use is defined as the sale, licensing, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial use of the Measures requires a license agreement between the user and NCQA. NCQA is not responsible for any use of the Measures. 

(c) 2012 National Committee for Quality Assurance. All Rights Reserved. 

Limited proprietary coding is contained in the Measure specifications for user convenience. Users of proprietary code sets should obtain all necessary licenses from the owners of the code sets.  NCQA disclaims all liability for use or accuracy of any CPT or other codes contained in the specifications.

CPT(R) contained in the Measure specifications is copyright 2004-2011 American Medical Association. LOINC (R) copyright 2004-2011 Regenstrief Institute, Inc. 
This material contains SNOMED Clinical Terms (R) (SNOMED CT[R]) copyright 2004-2011 International Health Terminology Standards Development Organisation.  ICD-10 Copyright 2011 World Health Organization. All Rights Reserved.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Disclaimer</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>These performance Measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications.

THE MEASURES AND SPECIFICATIONS ARE PROVIDED &#8220;AS IS&#8221; WITHOUT WARRANTY OF ANY KIND.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Scoring</span></td>
               <td width="80%" colspan="3">Proportion</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Type</span></td>
               <td width="80%" colspan="3">Process</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Stratification</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>None</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Risk Adjustment</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>None</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Rate Aggregation</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>None</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Rationale</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>A 10 percent decrease in total cholesterol levels (population wide) may result in an estimated 30 percent reduction in the incidence of coronary heart disease (CHD) (Centers for Disease Control and Prevention 2000). Based on data from the Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults:
&#8226;Less than half of persons who qualify for any kind of lipid-modifying treatment for CHD risk reduction are receiving it
&#8226;Less than half of even the highest-risk persons, those who have symptomatic CHD, are receiving lipid-lowering treatment
&#8226;Only about a third of treated patients are achieving their LDL goal; less than 20 percent of CHD patients are at their LDL goal (National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Pressure 2002)

According to data from the Behavioral Risk Factor Surveillance System (BRFSS) from 1991&#8211;2003, the prevalence of cholesterol screening during the preceding 5 years increased from 67.3 percent in 1991 to 73.1 percent in 2003 (Centers for Disease Control and Prevention 2005).

Between 1988&#8211;94 and 1999&#8211;2002, the age-adjusted mean total serum cholesterol level of adults20 years of age and  older decreased from 206 mg/dL to 203 mg/dL, and LDL cholesterol levels decreased from 129 mg/dL to 123 mg/dL. The mean level of LDL cholesterol for American adults age 20 and older is 123 mg/dL (Carroll et al. 2005). However, even given this decrease, there is still a significant amount of room for improvement.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Clinical Recommendation Statement</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002)

In high-risk persons, the recommended LDL-C goal is &lt; 100 mg/dL.

[1]An LDL-C goal of &lt; 70 mg/dL is a therapeutic option on the basis of available clinical trial evidence, especially for patients at very high risk.	

[2]If LDL-C is &gt; 100 mg/dL, an LDL-lowering drug is indicated simultaneously with lifestyle changes.

[3]If baseline LDL-C is &lt; 100 mg/dL, institution of an LDL-lowering drug to achieve an LDL-C level of &lt; 70 mg/dL is a therapeutic option on the basis of available clinical trial evidence.

[4]If a high-risk person has high triglycerides or low HDL-C, consideration can be given to combining a fibrate or nicotinic acid with an LDL-lowering drug. When triglycerides are &gt; 200 mg/dL, non-HDL-C is a secondary target of therapy, with a goal 30 mg/dL higher than the identified LDL-C goal.

The U.S. Preventive Services Task Force (USPSTF) strongly recommends screening men aged 35 and older for lipid disorders. This is a grade A recommendation. 

The USPSTF recommends screening men 20 to 25 years of age for lipid disorders if they are at increased risk for coronary heart disease. This is a grade B recommendation. 

The USPSTF strongly recommends screening women aged 45 and older for lipid disorders if they are at increased risk for coronary heart disease. This is a grade A recommendation. 

The USPSTF recommends screening women 20 to 45 years of age for lipid disorders if they are at increased risk for coronary heart disease. This is a grade B recommendation (U.S. Preventive Services Task Force 2008).</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Improvement Notation</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Higher score indicates better quality</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Centers for Disease Control and Prevention (CDC). 2005. &#8220;Trends in cholesterol screening and awareness of high blood cholesterol &#8211; United States, 1991-2003.&#8221; MMWR 54;865-870.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Carroll, M.D., D.A. Lacher, P.D. Sorlie, J.I. Cleeman, D.J. Gordon, M. Wolz, S.M. Grundy, C.L. Johnson. 2005. &#8220;Trends in serum lipids and lipoproteins of adults. 1960-2002.&#8221; JAMA 294:1773-1781.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Centers for Disease Control and Prevention (CDC). 2000. &#8220;State-specific cholesterol screening trends &#8211; United States, 1991-1999.&#8221; MMWR 49:750-755.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). 2002. &#8220;Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.&#8221; Circulation 106(25):3143-421.</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>U.S. Preventive Services Task Force. 2008. &#8220;Screening for lipid disorders in adults&#8221; (June) http://www.uspreventiveservicestaskforce.org/uspstf/uspschol.htm</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>None</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Guidance</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Only patients who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) are included in this measure</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Transmission Format</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>None</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Initial Patient Population</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Patients 18 years of age and older with a visit during the measurement period, and an active diagnosis of ischemic vascular disease (IVD) during the measurement period, or who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) in the 12 months prior to the measurement period</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Denominator</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Equals Initial Patient Population</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Denominator Exclusions</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Not Applicable</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Numerator</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Numerator 1: Patients with a complete lipid profile performed during the measurement period
Numerator 2: Patients whose most recent LDL-C level performed during the measurement period is &lt;100 mg/dL</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Numerator Exclusions</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Not Applicable</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Denominator Exceptions</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>None</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Population</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Not Applicable</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Observations</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>Not Applicable</pre></div>
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Supplemental Data Elements</span></td>
               <td width="80%" colspan="3">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto"><pre>For every patient evaluated by this measure also identify payer, race, ethnicity and sex.</pre></div>
               </td>
            </tr>
         </tbody>
      </table>
      <h2><a name="toc">Table of Contents</a></h2>
      <ul>
         <li><a href="#d2385461e508">Population criteria</a></li>
         <li><a href="#d2385461e1612">Data criteria (QDM Data Elements)</a></li>
         <li><a href="#d2385461e2221">Reporting Stratification</a></li>
         <li><a href="#d2385461e2242">Supplemental Data Elements</a></li>
      </ul>
      <hr align="left" color="teal" size="2" width="80%">
      <h3><a name="d2385461e508" href="#toc">Population criteria</a></h3>
      <div>
         
         <ul>
            <li>
               <b>Initial Patient Population =</b>
               
               <ul>
                  <li>AND: "Patient Characteristic Birthdate: birth date"  &gt;= 18 year(s) starts before start of "Measurement Period"</li>
                  <li>AND: 
                     <ul>
                        <li>OR: 
                           <ul>
                              <li>AND NOT: "Occurrence A of Diagnosis, Active: Ischemic Vascular Disease" ends before start of "Measurement Period"</li>
                              <li>AND: "Occurrence A of Diagnosis, Active: Ischemic Vascular Disease" starts before or during "Measurement Period"</li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>AND NOT: "Diagnosis, Active: Acute Myocardial Infarction" ends before start of "Measurement Period"</li>
                              <li>AND: "Occurrence A of Diagnosis, Active: Acute Myocardial Infarction"  &lt;= 12 month(s) starts before start of "Measurement
                                 Period"
                              </li>
                           </ul>
                           
                        </li>
                        <li>OR: 
                           <ul>
                              <li>OR: "Procedure, Performed: Percutaneous Coronary Interventions"</li>
                              <li>OR: "Procedure, Performed: Coronary Artery Bypass Graft"</li>
                              <li>  &lt;= 12 month(s) ends before start of "Measurement Period"</li>
                           </ul>
                           
                        </li>
                     </ul>
                     
                  </li>
                  <li>AND: 
                     <ul>
                        <li>OR: "Encounter, Performed: Office Visit"</li>
                        <li>OR: "Encounter, Performed: Face-to-Face Interaction"</li>
                        <li>OR: "Encounter, Performed: Preventive Care Services - Established Office Visit, 18 and Up"</li>
                        <li>OR: "Encounter, Performed: Preventive Care Services-Initial Office Visit, 18 and Up"</li>
                        <li>OR: "Encounter, Performed: Home Healthcare Services"</li>
                        <li>OR: "Encounter, Performed: Annual Wellness Visit"</li>
                        <li> during "Measurement Period"</li>
                     </ul>
                     
                  </li>
               </ul>
               
            </li>
            <li>
               <b>Denominator =</b>
               
               <ul>
                  <li>AND: "Initial Patient Population"</li>
               </ul>
               
            </li>
            <li>
               <b>Denominator Exclusions =</b>
               
               <ul>
                  <li>None</li>
               </ul>
               
            </li>
            <li>
               <b>Numerator 1 =</b>
               
               <ul>
                  <li>AND: 
                     <ul>
                        <li>OR: "Laboratory Test, Result: Complete Lipid Panel (result)"</li>
                        <li>OR: 
                           <ul>
                              <li>AND: "Laboratory Test, Result: Total Cholesterol Laboratory Test (result)"</li>
                              <li>AND: "Laboratory Test, Result: HDL-C Laboratory Test (result)"</li>
                              <li>AND: "Occurrence A of Laboratory Test, Result: LDL-C Laboratory Test (result)"</li>
                              <li>AND: "Laboratory Test, Result: Triglycerides Laboratory Test (result)"</li>
                           </ul>
                           
                        </li>
                        <li> during "Measurement Period"</li>
                     </ul>
                     
                  </li>
               </ul>
               
            </li>
            <li>
               <b>Numerator 2 =</b>
               
               <ul>
                  <li>AND:  MOST RECENT: "Occurrence A of Laboratory Test, Result: LDL-C Laboratory Test"</li>
                  <li>AND: "Occurrence A of Laboratory Test, Result: LDL-C Laboratory Test (result &lt; 100 mg/dL)" during "Measurement Period"</li>
               </ul>
               
            </li>
            <li>
               <b>Denominator Exceptions =</b>
               
               <ul>
                  <li>None</li>
               </ul>
               
            </li>
         </ul>
         
      </div>
      <h3><a name="d2385461e1612" href="#toc">Data criteria (QDM Data Elements)</a></h3>
      <div>
         
         <ul>
            <li>
               "Diagnosis, Active: Acute Myocardial Infarction" using "Acute Myocardial Infarction Grouping Value Set (2.16.840.1.113883.3.464.1003.104.12.1001)"
            </li>
            <li>
               "Diagnosis, Active: Ischemic Vascular Disease" using "Ischemic Vascular Disease Grouping Value Set (2.16.840.1.113883.3.464.1003.104.12.1003)"
            </li>
            <li>
               "Encounter, Performed: Annual Wellness Visit" using "Annual Wellness Visit Grouping Value Set (2.16.840.1.113883.3.526.3.1240)"
            </li>
            <li>
               "Encounter, Performed: Face-to-Face Interaction" using "Face-to-Face Interaction Grouping Value Set (2.16.840.1.113883.3.464.1003.101.12.1048)"
            </li>
            <li>
               "Encounter, Performed: Home Healthcare Services" using "Home Healthcare Services Grouping Value Set (2.16.840.1.113883.3.464.1003.101.12.1016)"
            </li>
            <li>
               "Encounter, Performed: Office Visit" using "Office Visit Grouping Value Set (2.16.840.1.113883.3.464.1003.101.12.1001)"
            </li>
            <li>
               "Encounter, Performed: Preventive Care Services - Established Office Visit, 18 and Up" using "Preventive Care Services - Established Office Visit, 18 and Up Grouping Value Set (2.16.840.1.113883.3.464.1003.101.12.1025)"
            </li>
            <li>
               "Encounter, Performed: Preventive Care Services-Initial Office Visit, 18 and Up" using "Preventive Care Services-Initial Office Visit, 18 and Up Grouping Value Set (2.16.840.1.113883.3.464.1003.101.12.1023)"
            </li>
            <li>
               "Laboratory Test, Result: Complete Lipid Panel" using "Complete Lipid Panel Grouping Value Set (2.16.840.1.113883.3.464.1003.104.12.1015)"
            </li>
            <li>
               "Laboratory Test, Result: HDL-C Laboratory Test" using "HDL-C Laboratory Test Grouping Value Set (2.16.840.1.113883.3.464.1003.104.12.1012)"
            </li>
            <li>
               "Laboratory Test, Result: LDL-C Laboratory Test" using "LDL-C Laboratory Test Grouping Value Set (2.16.840.1.113883.3.526.3.1248)"
            </li>
            <li>
               "Laboratory Test, Result: Total Cholesterol Laboratory Test" using "Total Cholesterol Laboratory Test Grouping Value Set (2.16.840.1.113883.3.464.1003.104.12.1013)"
            </li>
            <li>
               "Laboratory Test, Result: Triglycerides Laboratory Test" using "Triglycerides Laboratory Test Grouping Value Set (2.16.840.1.113883.3.464.1003.104.12.1014)"
            </li>
            <li>
               "Patient Characteristic Birthdate: birth date" using "birth date LOINC Value Set (2.16.840.1.113883.3.560.100.4)"
            </li>
            <li>
               "Procedure, Performed: Coronary Artery Bypass Graft" using "Coronary Artery Bypass Graft Grouping Value Set (2.16.840.1.113883.3.464.1003.104.12.1002)"
            </li>
            <li>
               "Procedure, Performed: Percutaneous Coronary Interventions" using "Percutaneous Coronary Interventions Grouping Value Set (2.16.840.1.113883.3.464.1003.104.12.1010)"
            </li>
         </ul>
         
      </div>
      <h3><a name="d2385461e2221" href="#toc">Reporting Stratification</a></h3>
      <div>
         
         <ul>
            <li>None</li>
         </ul>
         
      </div>
      <h3><a name="d2385461e2242" href="#toc">Supplemental Data Elements</a></h3>
      <div>
         
         <ul>
            <li>
               "Patient Characteristic Ethnicity: Ethnicity" using "Ethnicity CDC Value Set (2.16.840.1.114222.4.11.837)"
            </li>
            <li>
               "Patient Characteristic Payer: Payer" using "Payer Source of Payment Typology Value Set (2.16.840.1.114222.4.11.3591)"
            </li>
            <li>
               "Patient Characteristic Race: Race" using "Race CDC Value Set (2.16.840.1.114222.4.11.836)"
            </li>
            <li>
               "Patient Characteristic Sex: ONC Administrative Sex" using "ONC Administrative Sex Administrative Sex Value Set (2.16.840.1.113762.1.4.1)"
            </li>
         </ul>
         
      </div><br><hr align="left" color="teal" size="2" width="80%"><br><table class="header_table">
         <tbody>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Set</span></td>
               <td colspan="3" width="80%">
                  <div style="width:660px;overflow-x:hidden;overflow-y:auto;word-wrap:break-word">None</div>
               </td>
            </tr>
         </tbody>
      </table>
   </body>
</html>